azathioprine has been researched along with Infectious Diseases in 19 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (31.58) | 18.7374 |
| 1990's | 11 (57.89) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scott, FI | 1 |
| Vajravelu, RK | 1 |
| Bewtra, M | 1 |
| Mamtani, R | 1 |
| Lee, D | 1 |
| Goldberg, DS | 1 |
| Lewis, JD | 1 |
| Takatsu, N | 1 |
| Matsui, T | 1 |
| Murakami, Y | 1 |
| Ishihara, H | 1 |
| Hisabe, T | 1 |
| Nagahama, T | 1 |
| Maki, S | 1 |
| Beppu, T | 1 |
| Takaki, Y | 1 |
| Hirai, F | 1 |
| Yao, K | 1 |
| Cotter, PB | 1 |
| Weiter, JJ | 1 |
| Wadström, J | 1 |
| Brekke, B | 1 |
| Wramner, L | 1 |
| Ekberg, H | 1 |
| Tydén, G | 1 |
| Reichenspurner, H | 1 |
| Dienemann, H | 1 |
| Rihl, M | 1 |
| Wagner, F | 1 |
| Meiser, BM | 1 |
| Kur, F | 1 |
| Hammer, C | 1 |
| Forst, H | 1 |
| Kreuzer, E | 1 |
| Reichart, B | 1 |
| Pham, SM | 1 |
| Kormos, RL | 1 |
| Kawai, A | 1 |
| Murali, S | 1 |
| Hattler, BG | 1 |
| Demetris, AJ | 1 |
| Griffith, BP | 1 |
| Rossi, G | 1 |
| Reggiani, P | 1 |
| Orsenigo, R | 1 |
| Leoni, L | 1 |
| Caccamo, L | 1 |
| Doglia, M | 1 |
| Gatti, S | 1 |
| Maggi, U | 1 |
| Paone, G | 1 |
| Galmarini, D | 1 |
| Fassati, LR | 1 |
| Zuckermann, A | 1 |
| Birsan, T | 1 |
| Thaghavi, S | 1 |
| Artemiou, O | 1 |
| Kupilik, N | 1 |
| Dekan, G | 1 |
| Wolner, E | 1 |
| Klepetko, W | 1 |
| Van Buren, D | 1 |
| Payne, J | 1 |
| Geevarghese, S | 1 |
| MacDonell, R | 1 |
| Chapman, W | 1 |
| Wright, JK | 1 |
| Helderman, JH | 1 |
| Richie, R | 1 |
| Pinson, CW | 1 |
| Spillner, J | 1 |
| Kohnle, M | 1 |
| Albrecht, KH | 1 |
| Heemann, U | 1 |
| Tsai, MK | 1 |
| Lee, PH | 1 |
| Hu, RH | 1 |
| Lee, CJ | 1 |
| Tisone, G | 1 |
| Angelico, M | 1 |
| Orlando, G | 1 |
| Palmieri, GP | 1 |
| Strati, F | 1 |
| Di Paolo, D | 1 |
| Casciani, CU | 1 |
| Esmeraldo, RM | 1 |
| Donadi, MO | 1 |
| Oliveira, ML | 1 |
| Ponte, CN | 1 |
| Pinheiro, PM | 1 |
| Kirkman, RL | 1 |
| Shapiro, ME | 1 |
| Carpenter, CB | 1 |
| McKay, DB | 1 |
| Milford, EL | 1 |
| Ramos, EL | 1 |
| Tilney, NL | 1 |
| Waldmann, TA | 1 |
| Zimmerman, CE | 1 |
| Strom, TB | 1 |
| Takahashi, K | 1 |
| Yagisawa, T | 1 |
| Teraoka, S | 1 |
| Tanabe, K | 1 |
| Ebihara, K | 1 |
| Fuchinoue, S | 1 |
| Honda, H | 1 |
| Toma, T | 1 |
| Agishi, T | 1 |
| Ota, K | 1 |
| Oka, T | 1 |
| Omori, Y | 1 |
| Aikawa, I | 1 |
| Yasumura, T | 1 |
| Yoshimura, N | 1 |
| Yoshida, T | 1 |
| Kozaki, M | 1 |
| Hirano, T | 1 |
| Oka, K | 1 |
| Honma, M | 1 |
| Kang, X | 1 |
| Sakurai, E | 1 |
| Tamaki, T | 1 |
| Tamaki, I | 1 |
| Salaman, J | 1 |
| Abbud-Filho, M | 1 |
| Ramalho, HJ | 1 |
| Barberato, JB | 1 |
| Corrente, JE | 1 |
| Salgueiro, MC | 1 |
| Mazzetto, MR | 1 |
| Bezas, AG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Study of Compliance, Practice Patterns, and Barriers REgarding Established National Screening Programs for Barrett's Esophagus: SCREEN-BE[NCT04408105] | 725 participants (Actual) | Observational | 2020-02-19 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 trials available for azathioprine and Infectious Diseases
| Article | Year |
|---|---|
Triple versus quadruple induction immunosuppression in pancreas transplantation.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Communicable Diseases; Creatinine; Cyclosporine; Drug Res | 1995 |
Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Communicable Diseases; Coronary Disease; Cyclosporine; Dr | 1996 |
Mycophenolate mofetil in lung transplantation.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Communicable Diseases; Cyclosporine; Dr | 1998 |
Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients.
Topics: Adult; Analysis of Variance; Azathioprine; Communicable Diseases; Creatinine; Cyclosporine; Diabetes | 1998 |
Anti-LFA-1 monoclonal antibody in renal transplantation: renal function, infections, and other complications.
Topics: Antibodies, Monoclonal; Azathioprine; Communicable Diseases; Creatinine; Cyclosporine; Drug Therapy, | 1998 |
A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.
Topics: Antibodies, Monoclonal; Azathioprine; Communicable Diseases; Cyclosporins; Drug Therapy, Combination | 1991 |
Early conversion from cyclosporine to combination therapy with azathioprine in living related kidney transplantation.
Topics: Azathioprine; Clinical Trials as Topic; Communicable Diseases; Cyclosporins; Drug Administration Sch | 1989 |
Cyclosporine mono-drug therapy.
Topics: Azathioprine; Communicable Diseases; Cyclosporins; Drug Therapy, Combination; Graft Survival; Humans | 1988 |
11 other studies available for azathioprine and Infectious Diseases
| Article | Year |
|---|---|
The benefit-to-risk balance of combining infliximab with azathioprine varies with age: a markov model.
Topics: Adult; Age Factors; Aged; Azathioprine; Communicable Diseases; Crohn Disease; Drug Therapy, Combinat | 2015 |
Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease.
Topics: Adult; Alopecia; Aminosalicylic Acids; Anti-Inflammatory Agents; Asian People; Azathioprine; Chemica | 2009 |
Retinopathy in a patient with systemic lupus erythematosus.
Topics: Adult; Azathioprine; Communicable Diseases; Female; Humans; Lupus Erythematosus, Systemic; Prednison | 1982 |
Pulmonary rejection diagnosis after lung and heart-lung transplantation.
Topics: Azathioprine; Communicable Diseases; Cyclosporine; Diagnosis, Differential; Graft Rejection; Heart-L | 1993 |
Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience.
Topics: Administration, Oral; Adult; Azathioprine; Communicable Diseases; Female; Follow-Up Studies; Graft R | 1998 |
Infectious complications in renal transplant recipients: a 10-year review of cyclosporine-based immunosuppression.
Topics: Azathioprine; Cause of Death; Communicable Diseases; Cyclosporine; Drug Therapy, Combination; Graft | 1998 |
Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids.
Topics: Adult; Azathioprine; Communicable Diseases; Cyclosporine; Drug Therapy, Combination; Female; Humans; | 1999 |
Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
Topics: Adolescent; Adult; Aged; Azathioprine; Communicable Diseases; Cyclosporine; Dose-Response Relationsh | 1999 |
Infectious diseases in 450 kidney transplant recipients treated with cyclosporine in a single center.
Topics: Azathioprine; Communicable Diseases; Cyclosporins; Humans; Immunosuppression Therapy; Kidney Transpl | 1989 |
Postoperative endogenous serum cortisol levels as an index of acute rejection and severe infection in renal allograft recipients.
Topics: Azathioprine; Biomarkers; Communicable Diseases; Cyclosporins; Graft Rejection; Humans; Hydrocortiso | 1989 |
A prospective study of conversion from cyclosporine to azathioprine: comparison of clinical and morphologic findings.
Topics: Azathioprine; Communicable Diseases; Cyclosporins; Drug Administration Schedule; Graft Rejection; Gr | 1988 |